[en] Oncogene-induced cellular senescence (OIS) is emerging as a potent cancer-protective response to oncogenic events, serving to eliminate early neoplastic cells from the proliferative pool. Using combined genetic and bioinformatic analysis, we find that OIS is linked specifically to the activation of an inflammatory transcriptome. Induced genes included the pleiotropic cytokine interleukin-6 (IL-6), which upon secretion by senescent cells acted mitogenically in a paracrine fashion. Unexpectedly, IL-6 was also required for the execution of OIS, but in a cell-autonomous mode. Its depletion caused the inflammatory network to collapse and abolished senescence entry and maintenance. Furthermore, we demonstrate that the transcription factor C/EBPbeta cooperates with IL-6 to amplify the activation of the inflammatory network, including IL-8. In human colon adenomas, IL-8 specifically colocalized with arrested, p16(INK4A)-positive epithelium. We propose a model in which the context-dependent cytostatic and promitogenic functions of specific interleukins contribute to connect senescence with an inflammatory phenotype and cancer.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Kuilman, Thomas; The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands > Division of Molecular Genetics
Michaloglou, Chrysiis; The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands > Division of Molecular Genetics
Vredeveld, Liesbeth C. W.; The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands > Division of Molecular Genetics
Douma, Sirith; The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands > Division of Molecular Genetics
van Doorn, Remco; Leiden University Medical Center, 2300 RC Leiden, The Netherlands > Department of Dermatology,
Desmet, Christophe ; Université de Liège - ULiège > Département de sciences fonctionnelles > Physiologie
Acosta J.C., O'Loghlen A., Banito A., Guijarro M.V., Augert A., Raguz S., Fumagalli M., Da Costa M., Brown C., Popov N., et al. Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence. Cell 133 (2008) 1006-1018 this issue
Adams P.D. Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene 397 (2007) 84-93
Ancrile B., Lim K.H., and Counter C.M. Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev. 21 (2007) 1714-1719
Bartkova J., Rezaei N., Liontos M., Karakaidos P., Kletsas D., Issaeva N., Vassiliou L.V., Kolettas E., Niforou K., Zoumpourlis V.C., et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444 (2006) 633-637
Beausejour C.M., Krtolica A., Galimi F., Narita M., Lowe S.W., Yaswen P., and Campisi J. Reversal of human cellular senescence: Roles of the p53 and p16 pathways. EMBO J. 22 (2003) 4212-4222
Berns K., Hijmans E.M., Mullenders J., Brummelkamp T.R., Velds A., Heimerikx M., Kerkhoven R.M., Madiredjo M., Nijkamp W., Weigelt B., et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428 (2004) 431-437
Braig M., Lee S., Loddenkemper C., Rudolph C., Peters A.H., Schlegelberger B., Stein H., Dorken B., Jenuwein T., and Schmitt C.A. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436 (2005) 660-665
Brakenhoff J.P., de Hon F.D., Fontaine V., ten Boekel E., Schooltink H., Rose-John S., Heinrich P.C., Content J., and Aarden L.A. Development of a human interleukin-6 receptor antagonist. J. Biol. Chem. 269 (1994) 86-93
Campisi J. Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors. Cell 120 (2005) 513-522
Chen Z., Trotman L.C., Shaffer D., Lin H.K., Dotan Z.A., Niki M., Koutcher J.A., Scher H.I., Ludwig T., Gerald W., et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436 (2005) 725-730
Collado M., Gil J., Efeyan A., Guerra C., Schuhmacher A.J., Barradas M., Benguria A., Zaballos A., Flores J.M., Barbacid M., et al. Tumour biology: Senescence in premalignant tumours. Nature 436 (2005) 642
Courtois-Cox S., Genther Williams S.M., Reczek E.E., Johnson B.W., McGillicuddy L.T., Johannessen C.M., Hollstein P.E., MacCollin M., and Cichowski K. A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 10 (2006) 459-472
Dai C.Y., Furth E.E., Mick R., Koh J., Takayama T., Niitsu Y., and Enders G.H. p16(INK4a) expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferation. Gastroenterology 119 (2000) 929-942
Dankort D., Filenova E., Collado M., Serrano M., Jones K., and McMahon M. A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. Genes Dev. 21 (2007) 379-384
Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., Teague J., Woffendin H., Garnett M.J., Bottomley W., et al. Mutations of the BRAF gene in human cancer. Nature 417 (2002) 949-954
Denoyelle C., Abou-Rjaily G., Bezrookove V., Verhaegen M., Johnson T.M., Fullen D.R., Pointer J.N., Gruber S.B., Su L.D., Nikiforov M.A., et al. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat. Cell Biol. 8 (2006) 1053-1063
Di Micco R., Fumagalli M., Cicalese A., Piccinin S., Gasparini P., Luise C., Schurra C., Garre M., Nuciforo P.G., Bensimon A., et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444 (2006) 638-642
Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92 (1995) 9363-9367
Dirac A.M., and Bernards R. Reversal of senescence in mouse fibroblasts through lentiviral suppression of p53. J. Biol. Chem. 278 (2003) 11731-11734
Finkel T., Serrano M., and Blasco M.A. The common biology of cancer and ageing. Nature 448 (2007) 767-774
Garnett M.J., and Marais R. Guilty as charged: B-RAF is a human oncogene. Cancer Cell 6 (2004) 313-319
Gomis R.R., Alarcon C., Nadal C., Van Poznak C., and Massague J. C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 10 (2006) 203-214
Gray-Schopfer V.C., Cheong S.C., Chong H., Chow J., Moss T., Abdel-Malek Z.A., Marais R., Wynford-Thomas D., and Bennett D.C. Cellular senescence in naevi and immortalisation in melanoma: A role for p16?. Br. J. Cancer 95 (2006) 496-505
Ha L., Ichikawa T., Anver M., Dickins R., Lowe S., Sharpless N.E., Krimpenfort P., Depinho R.A., Bennett D.C., Sviderskaya E.V., et al. ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence. Proc. Natl. Acad. Sci. USA 104 (2007) 10968-10973
Hirano T., and Kishimoto T. Interleukin-6: Possible implications in human diseases. Ric. Clin. Lab. 19 (1989) 1-10
Hodge D.R., Xiao W., Clausen P.A., Heidecker G., Szyf M., and Farrar W.L. Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells. J. Biol. Chem. 276 (2001) 39508-39511
Hong D.S., Angelo L.S., and Kurzrock R. Interleukin-6 and its receptor in cancer: Implications for Translational Therapeutics. Cancer 110 (2007) 1911-1928
Kalai M., Montero-Julian F.A., Brakenhoff J.P., Fontaine V., De Wit L., Wollmer A., Brailly H., Content J., and Grotzinger J. Analysis of the mechanism of action of anti-human interleukin-6 and anti-human interleukin-6 receptor-neutralising monoclonal antibodies. Eur. J. Biochem. 249 (1997) 690-700
Kortlever R.M., Higgins P.J., and Bernards R. Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat. Cell Biol. 8 (2006) 877-884
Krimpenfort P., Ijpenberg A., Song J.Y., van der Valk M., Nawijn M., Zevenhoven J., and Berns A. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature 448 (2007) 943-946
Krtolica A., Parrinello S., Lockett S., Desprez P.Y., and Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging. Proc. Natl. Acad. Sci. USA 98 (2001) 12072-12077
Lloyd A.C., Obermuller F., Staddon S., Barth C.F., McMahon M., and Land H. Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev. 11 (1997) 663-677
Lowe S.W., Cepero E., and Evan G. Intrinsic tumour suppression. Nature 432 (2004) 307-315
Lu C., and Kerbel R.S. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J. Cell Biol. 120 (1993) 1281-1288
Mallette F.A., Gaumont-Leclerc M.F., and Ferbeyre G. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev. 21 (2007) 43-48
Mason D.X., Jackson T.J., and Lin A.W. Molecular signature of oncogenic ras-induced senescence. Oncogene 23 (2004) 9238-9246
Michaloglou C., Vredeveld L.C., Soengas M.S., Denoyelle C., Kuilman T., van der Horst C.M., Majoor D.M., Shay J.W., Mooi W.J., and Peeper D.S. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436 (2005) 720-724
Mooi W.J., and Peeper D.S. Oncogene-induced cell senescence-halting on the road to cancer. N. Engl. J. Med. 355 (2006) 1037-1046
Narita M., Nunez S., Heard E., Narita M., Lin A.W., Hearn S.A., Spector D.L., Hannon G.J., and Lowe S.W. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113 (2003) 703-716
Nicke B., Bastien J., Khanna S.J., Warne P.H., Cowling V., Cook S.J., Peters G., Delpuech O., Schulze A., Berns K., et al. Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cells. Mol. Cell 20 (2005) 673-685
Peeper D.S., Shvarts A., Brummelkamp T., Douma S., Koh E.Y., Daley G.Q., and Bernards R. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence. Nat. Cell Biol. 4 (2002) 148-153
Ramji D.P., and Foka P. CCAAT/enhancer-binding proteins: Structure, function and regulation. Biochem. J. 365 (2002) 561-575
Rowland B.D., Bernards R., and Peeper D.S. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat. Cell Biol. 7 (2005) 1074-1082
Sage J., Miller A.L., Perez-Mancera P.A., Wysocki J.M., and Jacks T. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424 (2003) 223-228
Schnabl B., Purbeck C.A., Choi Y.H., Hagedorn C.H., and Brenner D. Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. Hepatology 37 (2003) 653-664
Sebastian T., Malik R., Thomas S., Sage J., and Johnson P.F. C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence. EMBO J. 24 (2005) 3301-3312
Shay J.W., and Wright W.E. Senescence and immortalization: Role of telomeres and telomerase. Carcinogenesis 26 (2005) 867-874
Sherr C.J. Principles of tumor suppression. Cell 116 (2004) 235-246
Sparmann A., and Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6 (2004) 447-458
Tremain R., Marko M., Kinnimulki V., Ueno H., Bottinger E., and Glick A. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras. Oncogene 19 (2000) 1698-1709
Xue W., Zender L., Miething C., Dickins R.A., Hernando E., Krizhanovsky V., Cordon-Cardo C., and Lowe S.W. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445 (2007) 656-660
Ye X., Zerlanko B., Kennedy A., Banumathy G., Zhang R., and Adams P.D. Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells. Mol. Cell 27 (2007) 183-196
